Glenmark Pharma in Tie Up with Forest Lab for Inflammation Remedy
2
Glenmark Pharmaceuticals S.A (GPSA), a wholly owned subsidiary of Glenmark Pharmaceuticals, has entered into an agreement with Forest Laboratories, Inc. to collaborate on the development of inhibitors to treat chronic inflammatory conditions, including pa
